Colgate-Palmolive
1,681 hedge funds and large institutions have $51B invested in Colgate-Palmolive in 2023 Q2 according to their latest regulatory filings, with 113 funds opening new positions, 543 increasing their positions, 693 reducing their positions, and 81 closing their positions.
83% more call options, than puts
Call options by funds: $458M | Put options by funds: $250M
40% more first-time investments, than exits
New positions opened: 113 | Existing positions closed: 81
1% more funds holding
Funds holding: 1,658 → 1,681 (+23)
0.71% less ownership
Funds ownership: 80.43% → 79.73% (-0.71%)
7% less funds holding in top 10
Funds holding in top 10: 14 → 13 (-1)
11% less capital inflows, than outflows
Capital inflows: $3.64B | Capital outflows: $4.09B
22% less repeat investments, than reductions
Existing positions increased: 543 | Existing positions reduced: 693
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$1.08B |
| 2 |
Morgan Stanley
New York
|
+$342M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
+$126M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$119M |
| 5 |
Man Group
London,
United Kingdom
|
+$106M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Third Point
New York
|
-$830M |
| 2 |
BlackRock
New York
|
-$690M |
| 3 |
First Trust Advisors
Wheaton,
Illinois
|
-$197M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$170M |
| 5 |
D.E. Shaw & Co
New York
|
-$156M |
CL Hedge Fund Activity: Q2 2023 in Review
1,681 of the 6,389 institutional investors tracked by Wall St. Rank reported a position in Colgate-Palmolive (CL) for Q2 2023, worth a combined $51B — up 1.4% from $50.3B a quarter earlier.
Buyers outnumbered sellers: 113 funds opened new CL positions and 81 closed out — a net gain of 32 holders — while 543 added to existing stakes and 693 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $1.08B. The largest seller was Third Point, exiting entirely with an estimated $830M sold.
- 1,681 institutional investors held Colgate-Palmolive (CL) as of Q2 2023, up from 1,658 in Q1 2023.
- Funds reported $51B of Colgate-Palmolive stock for Q2 2023, up 1.4% quarter-over-quarter.
- 113 funds opened new Colgate-Palmolive positions in Q2 2023 and 81 closed out, a net change of +32 holders.
- The largest Colgate-Palmolive buyer in Q2 2023 was T. Rowe Price Associates, an estimated $1.08B added.
- The largest Colgate-Palmolive seller in Q2 2023 was Third Point, an estimated $830M sold.
Based on aggregated 13F filings for Q2 2023.